Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linyu Wu

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Oncoimmunology|January 10, 2022
Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancerShaoquan Zheng, Yutian Zou, Yuhui Tang, et al.
International Journal of Surgery (London, England)|November 7, 2022
Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgeryYutian Zou, Jindong Xie, Shaoquan Zheng, et al.
Cell Death & Disease|December 1, 2023
AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancerWenwen Tian, Yuhui Tang, Yongzhou Luo, et al.
Cell Death Discovery|January 5, 2024
PIWI-interacting RNA-YBX1 inhibits proliferation and metastasis by the MAPK signaling pathway via YBX1 in triple-negative breast cancerLinyu Wu, Shanshan Huang, Wenwen Tian, et al.
International Journal of Biological Sciences|April 14, 2023
Novel Implication of the Basement Membrane for Breast Cancer Outcome and Immune InfiltrationWenwen Tian, Yongzhou Luo, Yuhui Tang, et al.
Journal of Parkinson'S Disease|April 19, 2024
Identifying New Subtypes of Multiple System Atrophy Using Cluster AnalysisXiaobing Li, Jing Bai, Xin Guo, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 5, 2024
Toxicity profiles of immunochemotherapy for gastric or gastroesophageal junction adenocarcinoma: a systematic review and meta-analysisLinghong Wan, Fanxuan Tian, Lei Wang, et al.
Journal of Advanced Research|July 3, 2024
RNA modification gene WDR4 facilitates tumor progression and immunotherapy resistance in breast cancerYongzhou Luo, Wenwen Tian, Da Kang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 18, 2022
The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast CancerYutian Zou, Feng Ye, Yanan Kong, et al.
Medcomm|October 30, 2024
Reduced intestinal-to-diffuse conversion and immunosuppressive responses underlie superiority of neoadjuvant immunochemotherapy in gastric adenocarcinomaLei Wang, Linghong Wan, Xu Chen, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Oncoimmunology|January 10, 2022
Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancerShaoquan Zheng, Yutian Zou, Yuhui Tang, et al.
International Journal of Surgery (London, England)|November 7, 2022
Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgeryYutian Zou, Jindong Xie, Shaoquan Zheng, et al.
Cell Death & Disease|December 1, 2023
AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancerWenwen Tian, Yuhui Tang, Yongzhou Luo, et al.
Cell Death Discovery|January 5, 2024
PIWI-interacting RNA-YBX1 inhibits proliferation and metastasis by the MAPK signaling pathway via YBX1 in triple-negative breast cancerLinyu Wu, Shanshan Huang, Wenwen Tian, et al.
International Journal of Biological Sciences|April 14, 2023
Novel Implication of the Basement Membrane for Breast Cancer Outcome and Immune InfiltrationWenwen Tian, Yongzhou Luo, Yuhui Tang, et al.
Journal of Parkinson'S Disease|April 19, 2024
Identifying New Subtypes of Multiple System Atrophy Using Cluster AnalysisXiaobing Li, Jing Bai, Xin Guo, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 5, 2024
Toxicity profiles of immunochemotherapy for gastric or gastroesophageal junction adenocarcinoma: a systematic review and meta-analysisLinghong Wan, Fanxuan Tian, Lei Wang, et al.
Journal of Advanced Research|July 3, 2024
RNA modification gene WDR4 facilitates tumor progression and immunotherapy resistance in breast cancerYongzhou Luo, Wenwen Tian, Da Kang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 18, 2022
The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast CancerYutian Zou, Feng Ye, Yanan Kong, et al.
Medcomm|October 30, 2024
Reduced intestinal-to-diffuse conversion and immunosuppressive responses underlie superiority of neoadjuvant immunochemotherapy in gastric adenocarcinomaLei Wang, Linghong Wan, Xu Chen, et al.
Pageof 8